Piotr Garstecki
Vorstandsvorsitzender bei SCOPE FLUIDICS S.A.
Profil
Piotr Garstecki is the founder of Scope Fluidics SA and Curiosity Diagnostics Sp zoo, which were founded in 2010 and 2012 respectively.
At Scope Fluidics SA, he held the title of Chairman-Management Board, and at Curiosity Diagnostics Sp zoo, he held the title of Member-Management Board.
Dr. Garstecki earned a doctorate degree from the Polish Academy of Sciences in 2002.
Aktive Positionen von Piotr Garstecki
Unternehmen | Position | Beginn |
---|---|---|
SCOPE FLUIDICS S.A. | Vorstandsvorsitzender | - |
Curiosity Diagnostics Sp Zoo
Curiosity Diagnostics Sp Zoo Miscellaneous Commercial ServicesCommercial Services Part of Bio-Rad Laboratories, Inc., Curiosity Diagnostics Sp zoo is a Polish company that develops technology solutions for medical diagnostic and healthcare markets. The company is based in Warsaw, Poland. The company was founded by Szymon Ruta, Marcin Izydorzak, Piotr Garstecki. Marcin Izydorzak has been the CEO since incorporation. Curiosity Diagnostics was acquired by Bio-Rad Laboratories, Inc. from Scope Fluidics SA on August 03, 2022 for $36.98 million. | Gründer | 01.01.2012 |
Ausbildung von Piotr Garstecki
Polish Academy of Sciences | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SCOPE FLUIDICS S.A. | Health Technology |
Private Unternehmen | 1 |
---|---|
Curiosity Diagnostics Sp Zoo
Curiosity Diagnostics Sp Zoo Miscellaneous Commercial ServicesCommercial Services Part of Bio-Rad Laboratories, Inc., Curiosity Diagnostics Sp zoo is a Polish company that develops technology solutions for medical diagnostic and healthcare markets. The company is based in Warsaw, Poland. The company was founded by Szymon Ruta, Marcin Izydorzak, Piotr Garstecki. Marcin Izydorzak has been the CEO since incorporation. Curiosity Diagnostics was acquired by Bio-Rad Laboratories, Inc. from Scope Fluidics SA on August 03, 2022 for $36.98 million. | Commercial Services |